Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2026
Prognostic Value of Selected Epithelial-Mesenchymal Transition and Immune Checkpoint Markers in Predicting Malignant Transformation of Oral Leukoplakia.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Vijiakumar Jiveswara, Kallarakkal Thomas George, Karen-Ng Lee Peng, Siriwardena Samadara, Tilakaratne Wanninayake Mudiyanselage
Аннотация
AIM: This study investigates the prognostic potential of epithelial-mesenchymal transition (EMT) markers (E-cadherin, N-cadherin, Twist) and immune checkpoint markers (PD-1, PD-L1) in predicting malignant transformation (MT) of oral leukoplakia (OL).
METHODOLOGY: Immunohistochemistry (IHC) was performed on 56 OL tissue samples, categorized equally into progressive (transformed to higher-grade dysplasia or OSCC within 3 years) and non-progressive groups. Expression levels of E-cadherin, N-cadherin, Twist, PD-1, and PD-L1 were systematically assessed.
RESULTS: Progressive OL cases showed descriptive trends of lower E-cadherin expression, higher N-cadherin and Twist expression compared with non-progressive cases; however, these EMT-marker differences were not statistically significant. PD-1 expression was significantly higher in progressive OL (p = 0.038) compared with non-progressive OL. When stratified into non-progressive, dysplasia-progressive, and OSCC-progressive subsets, PD-L1 expression demonstrated significant variation (p = 0.018). Higher PD-1 expression was significantly associated with progressive OL in males (p = 0.02) and correlated with a shorter time to progression (τb = 0.456, p = 0.004).
CONCLUSION: The findings suggest that immune checkpoint markers, particularly PD-1 and PD-L1, may be associated with progression in OL and may warrant further validation as adjunctive prognostic markers.
METHODOLOGY: Immunohistochemistry (IHC) was performed on 56 OL tissue samples, categorized equally into progressive (transformed to higher-grade dysplasia or OSCC within 3 years) and non-progressive groups. Expression levels of E-cadherin, N-cadherin, Twist, PD-1, and PD-L1 were systematically assessed.
RESULTS: Progressive OL cases showed descriptive trends of lower E-cadherin expression, higher N-cadherin and Twist expression compared with non-progressive cases; however, these EMT-marker differences were not statistically significant. PD-1 expression was significantly higher in progressive OL (p = 0.038) compared with non-progressive OL. When stratified into non-progressive, dysplasia-progressive, and OSCC-progressive subsets, PD-L1 expression demonstrated significant variation (p = 0.018). Higher PD-1 expression was significantly associated with progressive OL in males (p = 0.02) and correlated with a shorter time to progression (τb = 0.456, p = 0.004).
CONCLUSION: The findings suggest that immune checkpoint markers, particularly PD-1 and PD-L1, may be associated with progression in OL and may warrant further validation as adjunctive prognostic markers.